Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP752625.RAWlHWaPz-wWl8cd7m6qBJPVomcy4xKjb8ImxrzWtiTlU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP752625.RAWlHWaPz-wWl8cd7m6qBJPVomcy4xKjb8ImxrzWtiTlU130_assertion type Assertion NP752625.RAWlHWaPz-wWl8cd7m6qBJPVomcy4xKjb8ImxrzWtiTlU130_head.
- NP752625.RAWlHWaPz-wWl8cd7m6qBJPVomcy4xKjb8ImxrzWtiTlU130_assertion description "[The objective of the study was to describe the antitumoral efficacy and toxicity of temozolomide in patients with aggressive pituitary tumors or carcinomas and evaluate the possible prognostic value of MGMT promoter methylation and protein expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP752625.RAWlHWaPz-wWl8cd7m6qBJPVomcy4xKjb8ImxrzWtiTlU130_provenance.
- NP752625.RAWlHWaPz-wWl8cd7m6qBJPVomcy4xKjb8ImxrzWtiTlU130_assertion evidence source_evidence_literature NP752625.RAWlHWaPz-wWl8cd7m6qBJPVomcy4xKjb8ImxrzWtiTlU130_provenance.
- NP752625.RAWlHWaPz-wWl8cd7m6qBJPVomcy4xKjb8ImxrzWtiTlU130_assertion SIO_000772 20660056 NP752625.RAWlHWaPz-wWl8cd7m6qBJPVomcy4xKjb8ImxrzWtiTlU130_provenance.
- NP752625.RAWlHWaPz-wWl8cd7m6qBJPVomcy4xKjb8ImxrzWtiTlU130_assertion wasDerivedFrom befree-20140225 NP752625.RAWlHWaPz-wWl8cd7m6qBJPVomcy4xKjb8ImxrzWtiTlU130_provenance.
- NP752625.RAWlHWaPz-wWl8cd7m6qBJPVomcy4xKjb8ImxrzWtiTlU130_assertion wasGeneratedBy ECO_0000203 NP752625.RAWlHWaPz-wWl8cd7m6qBJPVomcy4xKjb8ImxrzWtiTlU130_provenance.